Nanotech Company Awarded NASA Grant to Advance Nanoscale Drug Delivery
This month, Nanotrope, Inc. was awarded a $600,000 SBIR Phase II grant from NASA for its research in nanoscale droplet technology to enhance drug delivery. Small Business Innovation Research (SBIR) Phase II grants have a higher dollar amount than Phase I awards and are given to companies for prototype development to build on its initial research findings. Nanotrope plans to use its award to advance technology for new drug formulations and delivery procedures. Nanotrope's nanoscale droplet technology could prove of great benefit for NASA as well as the pharmaceuticals industry. The companyâ€™s nanodroplet generator technology can produce drug "containers" that carry precise delivery commands that target diseased cells and organs, allowing pharmaceutical companies to develop safer and more potent drugs.